Skip to main content

ImageneBio, Inc.

IMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001835579

In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding ImageneBio, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of IMA: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders3952+13
Shares25.0M31.2M+6.21M (+24.9%)
Value$86.2M$204.7M+$118.5M (+137.4%)

New holders (17)

Institutions that held ImageneBio, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to IMA in Q2 2023
InstitutionSharesValue% of portfolio
Avoro Capital Advisors LLC1,640,000$10.8M0.15%
Acuta Capital Partners, LLC558,000$3.66M2.48%
Adage Capital Partners GP, L.L.C.387,900$2.54M0.01%
Bank of New York Mellon Corp62,338$408.9K0.00%
Fred Alger Management, LLC41,252$270.6K0.00%
Nuveen Asset Management, LLC33,023$216.6K0.00%
Rhumbline Advisers21,428$140.6K0.00%
New York State Common Retirement Fund14,800$97.1K0.00%
Renaissance Technologies LLC14,094$92.0K0.00%
Mirae Asset Global Investments Co., Ltd.12,687$83.2K0.00%
MetLife Investment Management12,121$79.5K0.00%
American International Group, Inc.10,232$67.1K0.00%
California State Teachers Retirement System7,072$46.4K0.00%
Amalgamated Bank2,068$14.0K0.00%
Legal & General Group Plc2,045$13.4K0.00%
Ameritas Investment Partners, Inc.1,755$11.5K0.00%
Metropolitan Life Insurance Co1,256$8.24K0.00%

Sold out (4)

Institutions that held ImageneBio, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of IMA in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
DAFNA Capital Management LLC112,936$389.6K
Millennium Management LLC108,880$376.0K
Susquehanna International Group, LLP39,732$137.1K
Jane Street Group, LLC38,318$132.2K